Complete List of Hemoglobin S polymerization inhibitor Medicines
                
                
                
                    
                    
                        Brand: Oxbryta | 
                        Strength: 300 mg | 
                        Form: Tablets for Oral Suspension
                    
                    
                    
                        Class: | Hemoglobin S polymerization inhibitor  
Use: | Treatment of sickle cell disease in adults and pediatric patients aged 12 years and older  
Adult dose: | 300 mg orally once daily  
Pediatric d...
                    
                    
                 
                
                
                    
                    
                        Brand: Oxbryta | 
                        Strength: 300 mg | 
                        Form: Tablets for Oral Suspension
                    
                    
                    
                        Class: | Hemoglobin S polymerization inhibitor  
Use: | Treatment of sickle cell disease in patients aged 12 years and older  
Adult dose: | 300 mg once daily, taken orally  
Pediatric dose: | Not est...
                    
                    
                 
                
                
                    
                    
                        Brand: Oxbryta | 
                        Strength: 300 mg/tablet | 
                        Form: Dispersible Tablets
                    
                    
                    
                        Class: | Hemoglobin S polymerization inhibitor  
Use: | Treatment of sickle cell disease in patients aged 12 years and older  
Adult dose: | 300 mg once daily, taken orally  
Pediatric dose: | Not est...
                    
                    
                 
                
                
                    
                    
                        Brand: Oxbryta | 
                        Strength: 500 mg | 
                        Form: Film Coated Tablets
                    
                    
                    
                        Class: | Hemoglobin S polymerization inhibitor  
Use: | Treatment of sickle cell disease in adults and pediatric patients aged 12 years and older  
Adult dose: | 1,500 mg once daily  
Pediatric dose: ...